IL145736A0 - Combinations of gaba analogs and tricyclic compounds to treat depression - Google Patents

Combinations of gaba analogs and tricyclic compounds to treat depression

Info

Publication number
IL145736A0
IL145736A0 IL14573600A IL14573600A IL145736A0 IL 145736 A0 IL145736 A0 IL 145736A0 IL 14573600 A IL14573600 A IL 14573600A IL 14573600 A IL14573600 A IL 14573600A IL 145736 A0 IL145736 A0 IL 145736A0
Authority
IL
Israel
Prior art keywords
combinations
tricyclic compounds
treat depression
gaba analogs
gaba
Prior art date
Application number
IL14573600A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL145736A0 publication Critical patent/IL145736A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL14573600A 1999-04-09 2000-02-16 Combinations of gaba analogs and tricyclic compounds to treat depression IL145736A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12857199P 1999-04-09 1999-04-09
PCT/US2000/003983 WO2000061234A1 (en) 1999-04-09 2000-02-16 Combinations of gaba analogs and tricyclic compounds to treat depression

Publications (1)

Publication Number Publication Date
IL145736A0 true IL145736A0 (en) 2002-07-25

Family

ID=22435960

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14573600A IL145736A0 (en) 1999-04-09 2000-02-16 Combinations of gaba analogs and tricyclic compounds to treat depression

Country Status (11)

Country Link
EP (1) EP1180058A1 (xx)
JP (1) JP2002541224A (xx)
KR (1) KR20010108466A (xx)
AU (1) AU3492900A (xx)
CA (1) CA2367494A1 (xx)
HU (1) HUP0200733A3 (xx)
IL (1) IL145736A0 (xx)
NZ (1) NZ514401A (xx)
TR (1) TR200102850T2 (xx)
WO (1) WO2000061234A1 (xx)
ZA (1) ZA200108259B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
JP2005518411A (ja) * 2002-01-16 2005-06-23 エンド ファーマシューティカルズ インコーポレーテッド 中枢神経系の障害を治療する製薬組成物及び方法
CA2538412A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders
NZ545494A (en) * 2003-09-12 2009-10-30 Pfizer Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2410821A1 (de) * 1974-03-07 1975-09-18 Hoechst Ag Pharmazeutische kombinationspraeparate mit psychotroper wirkung und verfahren zu ihrer herstellung
FR2453643A2 (fr) * 1977-06-24 1980-11-07 Synthelabo Compositions pharmaceutiques actives sur le systeme nerveux central
US5025035A (en) * 1990-10-12 1991-06-18 Warner-Lambert Company Method of treating depression
WO1992009560A1 (en) * 1990-11-27 1992-06-11 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
EP0726073A3 (en) * 1995-02-10 1998-07-08 Eduardo Samuel Bleiweiss Pharmaceutical compositions containing at least one of haloperidol, imipramine or trifluoroperazine

Also Published As

Publication number Publication date
HUP0200733A3 (en) 2003-04-28
AU3492900A (en) 2000-11-14
JP2002541224A (ja) 2002-12-03
ZA200108259B (en) 2003-03-26
EP1180058A1 (en) 2002-02-20
NZ514401A (en) 2003-10-31
WO2000061234A1 (en) 2000-10-19
HUP0200733A2 (hu) 2002-07-29
TR200102850T2 (tr) 2002-03-21
KR20010108466A (ko) 2001-12-07
CA2367494A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
EP1005330A4 (en) METHODS AND COMPOSITIONS FOR TARGETING COMPOUNDS TO MUSCLES
HUP9900065A2 (hu) CGMP-foszfodiészteráz inhibitorok alkalmazása impotencia kezelésében
IL158420A0 (en) Use of follistatin to increase muscle mass
GB9705349D0 (en) Treatment of effluent streams
IL147748A0 (en) Use of etodolac to treat cancer
IL144926A0 (en) Distribution of calls to inquiry centers
EP1235785A4 (en) NEW CONNECTIONS FOR THE TREATMENT OF DIABETES AND ASSOCIATED DISEASES
IL145736A0 (en) Combinations of gaba analogs and tricyclic compounds to treat depression
IL146237A0 (en) Autotaxin variants and uses to treat diseases of metabolism
GB2353217B (en) Use of ribose to treat fibromyalgia
GB9923951D0 (en) Treatment of gas mixture
HUP0002896A3 (en) Use of polyelectrolytes as sequestering agents
GB2369574B (en) Initiation of oestrus
AU7057701A (en) New use as antihelmintics of albofungin and analogs
TW469837U (en) Improved structure of magnetically-controlled flywheel for exercise bicycle
TW431182U (en) Improved structure of massaging wheel
TW481990U (en) Structure of massage pedal
HUP0103568A3 (en) Treatment of depression
TW410639U (en) Improved structure of exercise wheel
TW408753U (en) Improved pedal fastening structure of bicycle
AU6191201A (en) Treatment of effluent
TW441356U (en) Structure of saddle-type massage pad
TW428489U (en) Structure of chess set
TW462310U (en) Improved structure of turning wheel for game device
TW410644U (en) Improved structure of exercise wheel